Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biotectid GmbH
Description mAb fragment that selectively binds to CD4 receptors on T lymphocytes
Molecular Target CD4
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I/II
Standard IndicationAutoimmune, Diagnostic
Indication DetailsDiagnose rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today